Search

Your search keyword '"Siegel, Erin M."' showing total 232 results

Search Constraints

Start Over You searched for: Author "Siegel, Erin M." Remove constraint Author: "Siegel, Erin M."
232 results on '"Siegel, Erin M."'

Search Results

201. The Functional Transcriptomic Landscape Informs Therapeutic Strategies in Multiple Myeloma.

202. Alcohol consumption and smoking history at time of diagnosis, and risk of colorectal cancer recurrence and mortality: Results from the ColoCare Study.

203. Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer.

204. Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic.

205. Age-related differences in employment, insurance, and financial hardship among colorectal cancer patients: a report from the ColoCare Study.

206. Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study.

207. Genomic Classification and Individualized Prognosis in Multiple Myeloma.

208. Spectrum of somatic mutational features of colorectal tumors in ancestrally diverse populations.

209. Risk Stratification for Early-onset Colorectal Cancer Screening: Are We Ready for Implementation?

210. Elevated EVL Methylation Level in the Normal Colon Mucosa Is a Potential Risk Biomarker for Developing Recurrent Adenomas.

211. Whole-Exome sequencing analysis identified TMSB10/TRABD2A locus to be associated with carfilzomib-related cardiotoxicity among patients with multiple myeloma.

212. Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomes.

213. Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study.

214. Low muscle mass is associated with a higher risk of all-cause and cardiovascular disease-specific mortality in cancer survivors.

215. Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients.

216. Individual-level factors associated with COVID-19 vaccine acceptance among U.S. patients with cancer.

217. Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients.

218. Presurgery Adhesion Molecules and Angiogenesis Biomarkers Are Differently Associated with Outcomes in Colon and Rectal Cancer: Results from the ColoCare Study.

219. Factors associated with changes in exercise behaviors during the COVID-19 pandemic.

220. Association of circulating leukocyte telomere length with survival in patients with colorectal cancer.

221. Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida.

222. Impact of the COVID-19 pandemic on exercise habits among cancer patients.

223. Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.

224. Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset.

225. Risk factors for cancer-related distress in colorectal cancer survivors: one year post surgery.

226. Publisher Correction: Shared heritability and functional enrichment across six solid cancers.

227. Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis.

228. Novel Common Genetic Susceptibility Loci for Colorectal Cancer.

229. Shared heritability and functional enrichment across six solid cancers.

230. Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.

231. Quantitative measures of visceral adiposity and body mass index in predicting rectal cancer outcomes after neoadjuvant chemoradiation.

232. Coccidioides posadasii contains a single 1,3-beta-glucan synthase gene that appears to be essential for growth.

Catalog

Books, media, physical & digital resources